About Us | Contact

Rajan Agarwal Investigator

Nuclear Radiology St Luke's Hospital Bethlehem NPI1871642017
Update NPI

Open Payments

Note

The following payment details are based on a national transparency program known as the Sunshine Act that collects and publishes information about financial relationships between the health care industry (i.e. drug and device manufactures) and providers. These relationships may involve payment to providers for things such as research, speaking engagment, travel, gifts etc. Not all of these payment involve monetary compensations and may include batering of drugs or devices.

Total Payment Worth

$4,606,372.87
from 826 payments in the last 6 years

Total Cash or Cash Equivalent

$4,605,130.63
from 819 payments in the last 6 years

Total In-kind Items & Services

$1,242.24
from 7 payments in the last 6 years

Nature of Payments

Last 6 Years
Chart will render here...

Yearly Breakdown

Chart will render here...

Payment Details

Date Payment Type Form of Payment Item/Service Payment Amount
09/27/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $637.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848721783
07/06/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $540.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848721571
08/02/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $480.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848721567
07/06/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $360.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848721459
04/08/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $4320.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848721453
01/27/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $2842.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848721019
04/08/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $660.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848717849
08/02/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $420.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848717349
10/06/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $2460.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848717279
05/07/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $80.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848717139
05/07/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $2100.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848717069
03/10/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $150.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848717067
10/06/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $1260.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848698581
06/08/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $25200.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848695235
02/04/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $1361.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848694841
05/07/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $3840.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848693613
08/02/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $14520.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848680169
08/02/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $1560.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848680051
05/20/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $2528.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848680033
06/08/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $1260.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848679893
04/08/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $395.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848679887
06/08/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $2760.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848679793
03/10/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $7420.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848677087
12/07/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $120.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848670981
11/05/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $13680.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848670979
12/15/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $3840.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848670835
12/07/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $2355.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848670833
11/05/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $17220.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848670827
05/07/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $240.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848658537
11/05/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $4980.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848658481
12/15/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $8250.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848658473
12/15/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $3480.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848658469
02/04/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $7460.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848658429
07/06/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $1060.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848658339
07/06/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $780.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848658261
08/02/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $320.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848658255
07/06/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $26980.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848658249
09/03/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $180.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848658163
04/08/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $1320.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848657723
05/07/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $10140.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848657721
02/04/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $60.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848657719
06/08/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $2895.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848657641
02/04/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $840.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848657635
03/10/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $240.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848657631
06/08/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $240.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848657403
12/15/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $5900.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848652839
11/05/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $5460.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848652837
12/15/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $2340.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848652701
06/08/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $3540.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848638099
03/10/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $300.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848637991
03/10/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $8340.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848637985
05/07/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $2700.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848628349
05/20/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $1121.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848628339
05/20/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $4980.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848628145
09/03/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $9710.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848627951
07/06/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $6120.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848627853
08/02/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $5850.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848627851
09/03/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $540.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848627849
07/06/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $4680.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848627847
02/04/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $4320.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848627825
12/15/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $900.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848627675
08/02/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $1740.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848616551
08/02/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $180.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848616437
05/07/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $420.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848615919
04/08/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $1710.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848615805
04/08/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $1620.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848615801
02/04/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $1015.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848615393
03/10/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $240.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848615111
12/07/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $3300.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848614345
12/07/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $435.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848614343
02/04/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $1440.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848610513
06/08/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $3240.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848609903
06/08/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $1440.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848609899
09/27/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $3857.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848609585
08/02/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $480.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848609335
09/03/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $300.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848609333
07/06/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $4440.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848609331
05/07/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $5780.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848609111
10/06/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $10500.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848601781
11/05/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $2700.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848590895
02/04/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $3420.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848587223
06/08/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $300.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848587221
02/04/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $2160.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848587213
08/02/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $10260.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848586685
12/07/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $14460.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848582279
05/07/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $25095.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848573121
12/15/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $180.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848573043
12/15/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $480.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848573041
06/08/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $18120.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848573011
08/02/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $6210.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848572643
07/06/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $14100.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848571869
04/08/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $420.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848569433
06/08/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $60.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848569425
08/02/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $600.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848569013
02/04/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $120.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848568721
04/08/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $660.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848568421
07/06/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $7290.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848568311
08/02/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $19320.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848568305
03/10/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $5170.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848568073
11/05/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $960.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848562307
12/07/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $600.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848562163
05/07/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $62.50 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848559443
03/10/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $4740.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848550373
10/06/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $300.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848550289
12/07/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $3840.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848550287
07/06/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $1320.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848550251
12/07/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $180.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848550145
12/15/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $1680.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848550143
08/02/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $62.50 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848550129
05/07/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $3195.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848545441
02/04/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $900.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848545433
12/15/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $7860.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848531503
10/06/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $4680.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848531499
02/04/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $480.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848531457
03/10/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $300.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848531357
05/20/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $300.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848531225
03/10/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $1620.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848530985
04/08/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $4380.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848530981
08/02/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $780.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848530919
01/07/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $2820.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848530731
02/04/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $4560.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848527681
06/08/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $7460.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848527563
07/06/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $180.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848522051
09/03/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $360.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848521817
08/02/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $3240.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848521815
10/06/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $62.50 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848521711
10/06/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $2580.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848521591
12/15/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $19860.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848521587
03/10/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $4740.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848520723
06/08/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $21495.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848509743
04/08/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $840.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848508997
11/05/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $840.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848508603
11/05/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $5460.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848508537
12/07/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $1440.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848508533
11/05/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $1440.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848508531
02/04/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $120.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848508381
09/03/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $11475.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848502411
12/15/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $1170.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848502041
11/05/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $60.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848501919
12/07/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $735.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848501795
11/05/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $240.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848501793
10/06/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $6660.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848501791
11/05/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $4860.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848501787
02/04/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $1140.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848490971
03/10/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $4140.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848490293
05/20/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $1661.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848489981
02/04/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $2070.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848489615
05/07/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $2220.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848480361
10/06/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $10680.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848480303
12/07/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $3255.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848480201
12/07/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $3240.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848480199
09/03/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $120.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848480075
08/02/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $3480.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848479967
06/08/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $2520.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848479949
02/11/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $240.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848479693
09/03/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $1080.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848479385
04/08/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $960.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848467211
06/08/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $240.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848467201
02/04/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $1560.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848467113
12/15/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $675.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848466429
12/15/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $1860.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848466419
07/06/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $360.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848465677
03/10/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $1740.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848462593
12/07/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $2970.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848462541
05/20/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $1315.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848461491
04/08/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $3240.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848445379
06/08/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $7980.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848445373
02/04/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $6240.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848445371
06/08/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $600.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848445257
07/06/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $1320.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848442497
11/05/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $400.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848442121
09/03/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $75.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848371401
05/20/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $3082.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848369863
05/07/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $480.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848369703
10/06/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $7440.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848314393
11/05/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $6920.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848314383
10/06/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $1395.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848314345
10/06/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $360.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848314335
12/15/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $6300.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848314333
10/06/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $600.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848314329
12/15/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $5760.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848314327
12/07/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $1120.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848314297
12/07/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $720.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848314293
10/06/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $480.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848314291
12/07/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $540.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848314283
12/07/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $4950.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848314281
12/07/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $400.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848314279
11/05/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $300.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848314235
11/05/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $2520.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848314229
11/05/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $2460.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848314227
10/06/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $360.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848314193
10/06/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $3060.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848314191
12/15/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $240.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848314189
12/15/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $1860.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848314185
10/06/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $1815.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848314135
11/05/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $9640.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848314067
10/06/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $8730.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848314065
12/07/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $8100.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848314055
10/06/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $780.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848314053
09/03/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $2970.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848309839
09/03/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $2820.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848309799
07/06/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $1980.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848309795
07/06/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $1860.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848309793
09/03/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $80.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848309709
07/06/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $80.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848309707
09/03/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $7260.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848309705
09/03/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $1320.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848309643
08/02/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $7140.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848309641
09/03/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $6030.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848309639
08/02/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $120.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848309439
02/04/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $60.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848309435
05/07/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $360.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848309433
03/10/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $300.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848309431
09/03/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $1080.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848309413
09/03/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $4275.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848309391
07/06/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $2700.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848309389
07/06/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $4230.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848309387
09/03/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $4020.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848309385
08/02/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $3240.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848309383
09/03/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $795.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848309361
04/08/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $5120.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848309335
02/04/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $4280.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848309333
03/10/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $3480.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848309327
05/07/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $2540.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848309307
04/08/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $2100.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848309289
04/08/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $1900.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848309287
05/07/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $11700.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848309149
02/04/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $9060.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848309135
06/10/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $142.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848308309
05/07/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $660.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848308161
02/04/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $660.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848308159
03/10/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $2160.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848308125
06/08/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $2100.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848308119
02/04/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $480.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848308077
05/07/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $3180.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848308067
03/10/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $2580.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848308065
03/10/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $14220.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848308043
04/08/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $120.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848308041
04/08/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $10140.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848308039
04/08/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $3960.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848308023
05/07/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $360.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848308021
05/07/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $960.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848307981
04/08/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $9480.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848307951
05/20/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $1860.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 848307889
02/04/2021 Research Cash or cash equivalent $17715.00 Details
Payment from E.R. Squibb & Sons, L.L.C.
Paymment Research Study Ph III MIBC Neoadjuvant 1L Bladder IDO Nivo chemo
Payment Record ID 819890735
05/07/2021 Research Cash or cash equivalent Biological $75.00 Details
Payment from E.R. Squibb & Sons, L.L.C.
Paymment Research Study I-O CC Seattle Genetics Phase IIa combo in NHL nivo brentuximab
Payment Record ID 819889967
06/08/2021 Research Cash or cash equivalent Biological $43605.00 Details
Payment from E.R. Squibb & Sons, L.L.C.
Paymment Research Study Phase III Adjuvant Bladder nivo mono
Payment Record ID 819889937
02/04/2021 Research Cash or cash equivalent Biological $31830.00 Details
Payment from E.R. Squibb & Sons, L.L.C.
Paymment Research Study Phase III Adjuvant HCC mono vs placebo
Payment Record ID 819889931
02/04/2021 Research Cash or cash equivalent Biological $16845.00 Details
Payment from E.R. Squibb & Sons, L.L.C.
Paymment Research Study Phase III Nivo Ipi Combo in 1L Bladder
Payment Record ID 819889889
02/04/2021 Research Cash or cash equivalent Biological $36990.00 Details
Payment from E.R. Squibb & Sons, L.L.C.
Paymment Research Study Phase III Nivo Ipi vs Placebo in Adjuvant RCC
Payment Record ID 819889883
02/04/2021 Research Cash or cash equivalent Biological $27870.00 Details
Payment from E.R. Squibb & Sons, L.L.C.
Paymment Research Study Phase III 1L Esophageal Nivo Ipi vs Nivo CT vs CT
Payment Record ID 819889872
02/04/2021 Research Cash or cash equivalent Biological $4012.50 Details
Payment from E.R. Squibb & Sons, L.L.C.
Paymment Research Study Phase IIB 1L NSCLC nivo ipi and nivo ipi chemo
Payment Record ID 819889867
02/04/2021 Research Cash or cash equivalent Biological $19140.00 Details
Payment from E.R. Squibb & Sons, L.L.C.
Paymment Research Study Phase III 1L Metastatic RCC Nivo Ipi Cabo
Payment Record ID 819889855
02/04/2021 Research Cash or cash equivalent Biological $18900.00 Details
Payment from E.R. Squibb & Sons, L.L.C.
Paymment Research Study Phase IIA Nivo in HL Pediatric nivo bv
Payment Record ID 819889843
02/04/2021 Research Cash or cash equivalent $1680.00 Details
Payment from Eli Lilly and Company
Paymment Research Study LIBRETTO-431: A MULTICENTER, RANDOMIZED, OPEN-LABEL, PHASE 3 TRIAL COMPARING LOXO-292 TO PLATINUM-BASED AND PEMETREXED THERAPY WITH OR WITHOUT PEMBROLIZUMAB AS INITIAL TREATMENT OF ADVANCED OR METASTATIC RET FUSION-POSITIVE NON-SMALL CELL LUNG CANCER
Payment Record ID 819446277
02/04/2021 Research Cash or cash equivalent $2340.00 Details
Payment from Eli Lilly and Company
Paymment Research Study A MULTICENTER, RANDOMIZED, OPEN LABEL, PHASE 3 TRIAL COMPARING SELPERCATINIB TO PHYSICIANS CHOICE OF CABOZANTINIB OR VANDETANIB IN PATIENTS WITH PROGRESSIVE, ADVANCED, KINASE INHIBITOR NAIVE, RET MUTANT MEDULLARY THYROID CANCER (LIBRETTO 531)
Clinical Trials Gov ID NCT04211337
Payment Record ID 819446203
02/04/2021 Research Cash or cash equivalent $2760.00 Details
Payment from Eli Lilly and Company
Paymment Research Study A PHASE 2 STUDY OF ORAL SELPERCATINIB (LOXO-292) IN PATIENTS WITH ADVANCED SOLID TUMORS, INCLUDING REARRANGED IN TRANSFECTION (RET) FUSION-POSITIVE SOLID TUMORS, MEDULLARY THYROID CANCER AND OTHER TUMORS WITH RET ACTIVATION
Clinical Trials Gov ID NCT04280081
Payment Record ID 819445905
09/22/2021 Research Cash or cash equivalent Biological $12184.17 Details
Payment from Regeneron Pharmaceuticals, Inc.
Paymment Research Study A TWO-PART RANDOMIZED, PHASE 3 STUDY OF COMBINATIONS OF CEMIPLIMAB (ANTI-PD-1 ANTIBODY) AND PLATINUM-BASED DOUBLET CHEMOTHERAPY IN FIRST-LINE TREATMENT OF PATIENTS WITH ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER
Clinical Trials Gov ID NCT03409614
Payment Record ID 793081187
06/03/2021 Research Cash or cash equivalent Biological $30720.00 Details
Payment from Regeneron Pharmaceuticals, Inc.
Paymment Research Study A TWO-PART RANDOMIZED, PHASE 3 STUDY OF COMBINATIONS OF CEMIPLIMAB (ANTI-PD-1 ANTIBODY) AND PLATINUM-BASED DOUBLET CHEMOTHERAPY IN FIRST-LINE TREATMENT OF PATIENTS WITH ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER
Clinical Trials Gov ID NCT03409614
Payment Record ID 793081185
05/20/2021 Research Cash or cash equivalent Biological $5880.00 Details
Payment from Regeneron Pharmaceuticals, Inc.
Paymment Research Study A GLOBAL, RANDOMISED, PHASE 3, OPEN-LABEL STUDY OF REGN2810 (ANTI-PD 1 ANTIBODY) VERSUS PLATINUM BASED CHEMOTHERAPY IN FIRST LINE TREATMENT OF PATIENTS WITH ADVANCED OR METASTATIC PD L1+NON-SMALL CELL LUNG CANCER
Clinical Trials Gov ID NCT03088540
Payment Record ID 793081183
02/04/2021 Research Cash or cash equivalent Biological $5222.00 Details
Payment from Regeneron Pharmaceuticals, Inc.
Paymment Research Study A GLOBAL, RANDOMISED, PHASE 3, OPEN-LABEL STUDY OF REGN2810 (ANTI-PD 1 ANTIBODY) VERSUS PLATINUM BASED CHEMOTHERAPY IN FIRST LINE TREATMENT OF PATIENTS WITH ADVANCED OR METASTATIC PD L1+NON-SMALL CELL LUNG CANCER
Clinical Trials Gov ID NCT03088540
Payment Record ID 793081175
10/07/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $1800.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747851063
10/07/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $180.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747851059
12/08/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $17190.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747851043
12/08/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $1680.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747851037
11/06/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $1520.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747850765
12/08/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $1440.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747850759
10/07/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $14220.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747850755
11/30/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $1200.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747850553
11/06/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $120.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747850548
11/06/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $120.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747850543
10/07/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $120.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747850539
10/07/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $120.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747850533
11/06/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $2460.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747850301
11/06/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $240.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747850297
12/08/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $11220.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747850221
11/30/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $960.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747850125
11/30/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $9360.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747850121
12/08/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $9240.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747850115
10/07/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $8520.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747850107
10/07/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $1920.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747850077
12/08/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $180.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747850071
10/07/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $120.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747849667
12/08/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $840.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747849651
11/30/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $8040.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747849647
11/30/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $780.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747849643
11/06/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $7380.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747849637
12/08/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $6600.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747849633
11/30/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $660.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747849627
12/08/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $6090.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747849621
11/06/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $960.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747849522
10/07/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $9270.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747849519
10/07/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $1140.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747849389
11/30/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $11250.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747849383
12/08/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $1080.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747849377
11/06/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $10170.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747849373
12/08/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $1620.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747849301
11/06/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $1260.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747849295
11/30/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $600.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747849041
11/06/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $60.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747849035
11/06/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $60.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747849031
11/30/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $60.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747849025
11/30/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $60.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747849019
11/30/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $60.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747849015
11/30/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $8340.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747848889
11/30/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $6660.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747848883
10/07/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $60.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747848753
11/06/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $5880.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747848747
12/08/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $5800.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747848457
10/07/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $561.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747848446
11/30/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $5580.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747848441
11/06/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $5100.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747848437
10/07/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $510.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747848433
11/30/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $4770.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747848427
12/08/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $4560.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747848423
10/07/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $4500.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747848137
11/06/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $60.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747848043
11/30/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $60.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747848039
10/07/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $4380.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747847899
12/08/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $3900.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747847893
12/08/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $390.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747847887
11/30/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $3180.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747847877
12/08/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $2670.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747847871
12/08/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $240.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747847383
12/08/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $240.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747847379
11/06/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $240.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747847373
11/06/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $240.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747847369
11/30/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $240.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747847363
11/30/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $240.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747847357
10/07/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $2340.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747847353
11/30/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $5400.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747847251
11/06/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $4080.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747847235
10/07/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $360.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747847229
11/06/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $2130.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747847103
10/07/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $2130.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747847099
11/06/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $1800.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747847093
10/26/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $1800.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747839227
11/24/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $2580.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747829023
11/19/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $2520.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747829021
11/25/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $202.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747829019
11/25/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $1942.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747829017
11/25/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $1560.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747829013
11/24/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $1320.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747828887
11/25/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $1282.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747828783
08/06/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $1230.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747804205
09/08/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $120.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747804203
09/08/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $120.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747804201
08/06/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $120.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747804199
09/08/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $11880.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747804197
08/06/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $11580.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747804195
07/08/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $1140.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747804053
09/08/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $11040.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747804051
09/08/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $10020.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747804049
09/08/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $600.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747802691
07/08/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $480.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747802617
08/06/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $400.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747802615
08/06/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $5160.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747802545
07/08/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $4880.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747802543
09/08/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $4740.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747802541
07/08/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $4560.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747802539
08/06/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $3780.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747802537
09/08/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $9600.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747802519
07/08/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $8640.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747802517
08/06/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $8340.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747802515
08/06/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $270.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747802475
09/08/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $3300.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747802419
07/08/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $3120.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747802417
07/08/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $300.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747802415
07/08/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $7920.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747802401
08/06/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $7140.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747802395
07/08/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $660.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747802393
07/08/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $1500.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747802363
07/08/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $13590.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747802361
09/08/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $120.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747802359
07/08/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $11580.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747802355
08/06/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $60.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747802293
09/08/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $2700.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747802279
08/06/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $2020.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747802277
09/08/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $185.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747802275
09/08/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $180.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747802273
07/08/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $150.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747802271
07/08/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $150.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747802269
07/08/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $150.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747802267
07/08/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $600.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747802243
09/08/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $60.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747802239
08/06/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $60.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747802237
08/06/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $14400.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747802145
08/06/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $1380.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747802141
08/06/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $60.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747802119
09/08/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $560.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747802117
09/08/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $5460.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747802115
09/08/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $540.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747802113
08/06/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $540.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747802111
10/15/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $5393.50 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747798119
10/15/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $284.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747798117
10/15/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $195.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747798115
10/15/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $1781.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747798113
10/15/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $1730.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747798111
10/15/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $1680.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747798109
10/15/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $120.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747798107
10/15/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $1195.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747798105
10/15/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $2982.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747798041
08/26/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $3754.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747760927
06/11/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $4440.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747760545
06/11/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $2261.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747760543
06/04/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $2043.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747760541
02/05/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $1530.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747625053
05/06/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $1140.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747625045
03/11/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $150.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747624991
03/11/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $1440.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747624989
05/06/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $360.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747624595
04/08/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $3000.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747624539
05/06/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $2700.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747624537
06/10/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $900.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747624123
04/08/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $780.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747624121
04/08/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $6900.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747624115
03/11/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $6720.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747624099
06/10/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $60.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747624089
02/05/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $60.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747624087
06/10/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $5340.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747624063
06/10/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $5280.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747624061
03/11/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $4380.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747624037
04/08/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $4230.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747624035
03/11/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $3780.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747624007
04/08/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $180.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747623163
03/11/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $180.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747623161
01/03/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $180.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747623159
01/03/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $1620.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747623157
06/10/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $1500.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747623155
06/10/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $150.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747623151
01/03/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $1110.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747623145
01/03/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $11040.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747623143
06/10/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $150.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747623099
04/08/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $150.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747623013
02/05/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $150.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747622961
02/05/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $1440.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747622955
04/08/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $1320.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747622951
02/05/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $1320.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747622949
05/06/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $1260.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747622753
03/11/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $1260.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747622751
05/06/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $125.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747622749
04/08/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $125.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747622747
02/05/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $120.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747622745
02/05/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $120.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747622695
02/05/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $120.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747622693
01/03/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $120.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747622691
01/03/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $11580.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747622689
01/03/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $960.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747622609
02/05/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $900.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747622607
01/03/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $900.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747622605
01/03/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $840.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747622603
04/08/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $780.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747622601
03/11/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $780.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747622599
06/10/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $7560.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747622597
06/10/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $741.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747622565
02/05/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $600.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747622541
05/06/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $60.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747622539
04/08/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $60.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747622537
01/03/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $60.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747622533
01/03/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $60.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747622531
03/11/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $7020.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747622501
02/05/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $7020.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747622499
04/08/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $690.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747622497
05/06/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $5700.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747622495
06/10/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $5400.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747622493
01/03/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $9720.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747622467
06/10/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $680.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747622461
06/10/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $6750.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747622459
05/06/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $6450.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747622457
05/06/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $6210.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747622455
04/08/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $5400.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747622409
04/08/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $5340.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747622405
03/11/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $5340.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747622403
03/11/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $5220.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747622401
04/08/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $4890.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747622399
05/06/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $4860.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747622397
05/06/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $480.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747622395
01/03/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $480.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747622361
02/05/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $4500.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747622359
04/08/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $4320.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747622357
02/05/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $4320.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747622355
05/06/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $4200.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747622351
06/10/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $420.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747622349
04/08/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $420.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747622347
05/06/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $390.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747622311
03/11/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $3660.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747622309
05/06/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $360.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747622305
02/05/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $360.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747622303
06/10/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $3360.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747622301
06/10/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $3200.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747622299
06/10/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $300.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747622265
05/06/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $300.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747622263
03/11/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $300.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747622261
01/03/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $300.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747622259
06/10/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $240.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747622257
06/10/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $240.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747622255
02/05/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $2340.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747622253
05/06/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $2160.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747622251
05/27/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $540.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747619427
05/27/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $4105.50 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747619425
05/27/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $2966.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747619423
05/27/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $240.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747619405
05/08/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $360.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747619085
04/02/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $900.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747618751
02/06/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $5447.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747618749
04/02/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $4272.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747618747
04/02/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $3840.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747618743
04/02/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $240.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747618741
02/06/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $1860.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747618739
04/02/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $600.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747618625
01/30/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $3150.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747617517
01/09/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $6620.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747614995
01/23/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $420.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747614993
01/30/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $363.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747614991
01/30/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $2940.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747614989
01/09/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $2680.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747614987
04/08/2020 Research Cash or cash equivalent Biological $1500.00 Details
Payment from E.R. Squibb & Sons, L.L.C.
Paymment Research Study I-O CC Seattle Genetics Phase IIa combo in NHL nivo brentuximab
Payment Record ID 736765501
08/06/2020 Research Cash or cash equivalent Biological $4170.00 Details
Payment from E.R. Squibb & Sons, L.L.C.
Paymment Research Study Multi-Center Phase II Open-Label Study to Evaluate Safety and Efficacy in Subjects with Melanoma Metastatic to the Brain Treated with Nivolumab in Combinatiion with Ipilimumab followed by Nivolumab Monotherapy
Payment Record ID 736765483
01/29/2020 Research Cash or cash equivalent $2490.00 Details
Payment from E.R. Squibb & Sons, L.L.C.
Paymment Research Study Ph III MIBC Neoadjuvant 1L Bladder IDO Nivo chemo
Payment Record ID 736765455
01/27/2020 Research Cash or cash equivalent $8400.00 Details
Payment from E.R. Squibb & Sons, L.L.C.
Paymment Research Study Phase I IIA FIH Nivo Combination with Monotherapy Run-in
Payment Record ID 736765435
01/28/2020 Research Cash or cash equivalent Biological $7675.00 Details
Payment from E.R. Squibb & Sons, L.L.C.
Paymment Research Study Phase IIB 1L NSCLC nivo ipi and nivo ipi chemo
Payment Record ID 736765391
01/28/2020 Research Cash or cash equivalent Biological $25625.00 Details
Payment from E.R. Squibb & Sons, L.L.C.
Paymment Research Study Phase IIB Colon Cancer MSI nivo mono and combo
Payment Record ID 736765379
04/08/2020 Research Cash or cash equivalent Biological $27150.00 Details
Payment from E.R. Squibb & Sons, L.L.C.
Paymment Research Study Phase IIB MSI High CRC PMR
Payment Record ID 736765367
01/27/2020 Research Cash or cash equivalent Biological $21437.50 Details
Payment from E.R. Squibb & Sons, L.L.C.
Paymment Research Study Phase IIB Signal Detection Single arm, PD-1 TNBC, SCLC, pancreatic, gastric, bladder, Ovarian Mono and Combo
Payment Record ID 736765361
01/27/2020 Research Cash or cash equivalent Biological $66540.00 Details
Payment from E.R. Squibb & Sons, L.L.C.
Paymment Research Study Phase III 1L Esophageal Nivo Ipi vs Nivo CT vs CT
Payment Record ID 736765343
01/27/2020 Research Cash or cash equivalent Biological $56910.00 Details
Payment from E.R. Squibb & Sons, L.L.C.
Paymment Research Study Phase III 1L Gastric nivo ipi vs nivo CT vs CT
Payment Record ID 736765331
01/28/2020 Research Cash or cash equivalent Biological $56520.00 Details
Payment from E.R. Squibb & Sons, L.L.C.
Paymment Research Study Phase III 1L Metastatic RCC Nivo Ipi Cabo
Payment Record ID 736765319
01/27/2020 Research Cash or cash equivalent Biological $37140.00 Details
Payment from E.R. Squibb & Sons, L.L.C.
Paymment Research Study Phase III 1L NSCLC nivo ipi chemo vs chemo in PDL-1 all comers
Payment Record ID 736765307
01/29/2020 Research Cash or cash equivalent Biological $47610.00 Details
Payment from E.R. Squibb & Sons, L.L.C.
Paymment Research Study Phase III Adjuvant HCC mono vs placebo
Payment Record ID 736765297
01/28/2020 Research Cash or cash equivalent Biological $48870.00 Details
Payment from E.R. Squibb & Sons, L.L.C.
Paymment Research Study Phase III Nivo Ipi vs Placebo in Adjuvant RCC
Payment Record ID 736765263
05/06/2020 Research Cash or cash equivalent Biological $150.00 Details
Payment from E.R. Squibb & Sons, L.L.C.
Paymment Research Study Phase III Randomized Study of Opdivo+Doc vs Doc in chemo-nave mCRPC
Payment Record ID 736765225
11/06/2020 Research Cash or cash equivalent Biological $225.00 Details
Payment from E.R. Squibb & Sons, L.L.C.
Paymment Research Study Phase III Stage III Unresectable NSCLC Combo
Payment Record ID 736765221
11/06/2020 Research Cash or cash equivalent $1620.00 Details
Payment from Eli Lilly and Company
Paymment Research Study A PHASE 2 STUDY OF ORAL SELPERCATINIB (LOXO-292) IN PATIENTS WITH ADVANCED SOLID TUMORS, INCLUDING REARRANGED IN TRANSFECTION (RET) FUSION-POSITIVE SOLID TUMORS, MEDULLARY THYROID CANCER AND OTHER TUMORS WITH RET ACTIVATION
Clinical Trials Gov ID NCT04280081
Payment Record ID 728723917
02/05/2020 Research Cash or cash equivalent $1080.00 Details
Payment from Eli Lilly and Company
Paymment Research Study A MULTICENTER, RANDOMIZED, OPEN LABEL, PHASE 3 TRIAL COMPARING SELPERCATINIB TO PHYSICIANS CHOICE OF CABOZANTINIB OR VANDETANIB IN PATIENTS WITH PROGRESSIVE, ADVANCED, KINASE INHIBITOR NAIVE, RET MUTANT MEDULLARY THYROID CANCER (LIBRETTO 531)
Clinical Trials Gov ID NCT04211337
Payment Record ID 728723389
03/11/2020 Research Cash or cash equivalent $570.00 Details
Payment from Eli Lilly and Company
Paymment Research Study LIBRETTO-431: A MULTICENTER, RANDOMIZED, OPEN-LABEL, PHASE 3 TRIAL COMPARING LOXO-292 TO PLATINUM-BASED AND PEMETREXED THERAPY WITH OR WITHOUT PEMBROLIZUMAB AS INITIAL TREATMENT OF ADVANCED OR METASTATIC RET FUSION-POSITIVE NON-SMALL CELL LUNG CANCER
Payment Record ID 728722977
12/01/2020 Research Cash or cash equivalent Biological $4860.00 Details
Payment from Regeneron Pharmaceuticals, Inc.
Paymment Research Study A TWO-PART RANDOMIZED, PHASE 3 STUDY OF COMBINATIONS OF CEMIPLIMAB (ANTI-PD-1 ANTIBODY) AND PLATINUM-BASED DOUBLET CHEMOTHERAPY IN FIRST-LINE TREATMENT OF PATIENTS WITH ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER
Clinical Trials Gov ID NCT03409614
Payment Record ID 724430305
12/03/2020 Research Cash or cash equivalent Biological $10320.00 Details
Payment from Regeneron Pharmaceuticals, Inc.
Paymment Research Study A TWO-PART RANDOMIZED, PHASE 3 STUDY OF COMBINATIONS OF CEMIPLIMAB (ANTI-PD-1 ANTIBODY) AND PLATINUM-BASED DOUBLET CHEMOTHERAPY IN FIRST-LINE TREATMENT OF PATIENTS WITH ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER
Clinical Trials Gov ID NCT03409614
Payment Record ID 724430301
12/03/2020 Research Cash or cash equivalent Biological $17820.00 Details
Payment from Regeneron Pharmaceuticals, Inc.
Paymment Research Study A TWO-PART RANDOMIZED, PHASE 3 STUDY OF COMBINATIONS OF CEMIPLIMAB (ANTI-PD-1 ANTIBODY) AND PLATINUM-BASED DOUBLET CHEMOTHERAPY IN FIRST-LINE TREATMENT OF PATIENTS WITH ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER
Clinical Trials Gov ID NCT03409614
Payment Record ID 724430287
10/15/2020 Research Cash or cash equivalent Biological $5099.50 Details
Payment from Regeneron Pharmaceuticals, Inc.
Paymment Research Study A GLOBAL, RANDOMISED, PHASE 3, OPEN-LABEL STUDY OF REGN2810 (ANTI-PD 1 ANTIBODY) VERSUS PLATINUM BASED CHEMOTHERAPY IN FIRST LINE TREATMENT OF PATIENTS WITH ADVANCED OR METASTATIC PD L1+NON-SMALL CELL LUNG CANCER
Clinical Trials Gov ID NCT03088540
Payment Record ID 724430283
05/21/2020 Research Cash or cash equivalent Biological $5638.50 Details
Payment from Regeneron Pharmaceuticals, Inc.
Paymment Research Study A GLOBAL, RANDOMISED, PHASE 3, OPEN-LABEL STUDY OF REGN2810 (ANTI-PD 1 ANTIBODY) VERSUS PLATINUM BASED CHEMOTHERAPY IN FIRST LINE TREATMENT OF PATIENTS WITH ADVANCED OR METASTATIC PD L1+NON-SMALL CELL LUNG CANCER
Clinical Trials Gov ID NCT03088540
Payment Record ID 724430261
04/23/2020 Research Cash or cash equivalent Biological $16858.00 Details
Payment from Regeneron Pharmaceuticals, Inc.
Paymment Research Study A TWO-PART RANDOMIZED, PHASE 3 STUDY OF COMBINATIONS OF CEMIPLIMAB (ANTI-PD-1 ANTIBODY) AND PLATINUM-BASED DOUBLET CHEMOTHERAPY IN FIRST-LINE TREATMENT OF PATIENTS WITH ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER
Clinical Trials Gov ID NCT03409614
Payment Record ID 724430251
12/31/2019 Research Cash or cash equivalent Biological $150.00 Details
Payment from E.R. Squibb & Sons, L.L.C.
Paymment Research Study Phase III Stage III Unresectable NSCLC Combo
Payment Record ID 708417629
12/19/2019 Research Cash or cash equivalent $1215.00 Details
Payment from E.R. Squibb & Sons, L.L.C.
Paymment Research Study Ph III MIBC Neoadjuvant 1L Bladder IDO Nivo chemo
Payment Record ID 708417607
06/03/2019 General (Non-Research) Cash or cash equivalent Food and Beverage $16.11 Details
Payment from GE HEALTHCARE
Payment Record ID 698466535
12/11/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $480.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695889017
11/07/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $330.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695889015
11/07/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $300.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695889013
10/09/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $180.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695889011
11/07/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $1350.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695889009
11/07/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $990.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695887301
12/11/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $6720.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695887299
11/07/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $6630.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695887297
10/09/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $6300.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695887295
12/11/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $60.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695887293
11/07/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $60.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695887291
10/09/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $60.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695887289
10/09/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $480.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695887287
11/07/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $4560.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695887285
10/09/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $4020.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695887283
12/11/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $360.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695887123
11/07/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $360.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695887121
10/09/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $360.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695887119
11/07/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $3540.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695887117
10/09/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $330.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695887115
12/11/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $300.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695887113
10/09/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $2400.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695887111
12/11/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $240.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695887109
12/11/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $210.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695887107
12/11/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $180.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695886951
11/07/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $1505.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695886949
11/07/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $150.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695886945
10/09/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $1245.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695886943
12/11/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $120.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695886941
12/11/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $120.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695886939
10/09/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $120.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695886793
12/11/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $1170.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695886791
12/11/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $6570.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695886571
12/19/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $4057.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695877241
12/19/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $120.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695877239
12/12/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $1190.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695877237
11/30/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $10133.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695877235
12/12/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $6451.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695876215
11/07/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $2640.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695871481
08/08/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $60.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695833203
07/01/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $510.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695833201
07/01/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $360.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695833199
09/03/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $1980.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695833197
09/03/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $900.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695832909
09/03/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $840.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695832907
07/01/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $660.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695832905
07/01/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $60.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695832903
09/03/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $5760.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695832901
08/08/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $5640.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695832899
08/08/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $480.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695832781
07/01/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $4200.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695832779
08/08/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $420.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695832777
07/01/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $360.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695832775
08/08/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $330.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695832773
09/03/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $3000.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695832675
09/03/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $300.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695832673
08/08/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $240.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695832671
08/08/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $240.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695832547
09/03/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $210.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695832545
08/08/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $1980.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695832543
07/01/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $1320.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695832541
09/03/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $120.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695832539
08/08/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $1140.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695832537
10/10/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $9568.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695824985
09/25/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $4951.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695824983
09/25/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $2680.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695824981
10/17/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $240.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695824979
09/25/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $180.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695824811
10/10/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $10707.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695824809
09/25/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $2810.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695824101
08/22/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $6508.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695728241
08/22/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $60.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695728239
08/01/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $60.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695728181
08/01/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $3770.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695728137
08/22/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $262.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695728081
08/22/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $21008.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695728017
06/20/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $442.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695700983
06/20/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $60.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695700649
06/06/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $26648.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695700647
06/06/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $12382.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695700645
04/10/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $960.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695700467
05/01/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $600.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695700465
06/03/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $60.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695700463
06/03/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $3660.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695700461
05/01/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $2040.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695700459
06/03/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $1750.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695700457
02/11/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $1710.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695700455
05/01/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $1440.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695700453
05/01/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $120.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695700451
05/01/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $120.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695700347
05/01/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $110.10 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695700345
04/10/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $1020.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695700343
06/03/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $720.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695699957
06/03/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $480.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695699955
04/10/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $120.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695699953
06/03/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $960.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695699839
05/23/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $9861.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695612349
05/30/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $8646.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695610047
05/02/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $660.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695610044
05/02/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $562.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695610039
05/16/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $562.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695610037
05/20/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $25952.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695610031
05/16/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $1623.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695609873
03/30/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $685.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695503505
03/01/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $840.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695502976
02/14/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $60.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695502349
03/01/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $240.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695502343
01/16/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $1080.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695502341
03/21/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $7525.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695501639
03/21/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $7347.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695501632
01/10/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $682.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695501453
04/11/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $5433.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695501449
04/11/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $360.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695501445
01/10/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $120.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695501437
02/14/2019 Research Cash or cash equivalent Biological $50475.00 Details
Payment from E.R. Squibb & Sons, L.L.C.
Paymment Research Study Phase III Nivo Ipi vs Placebo in Adjuvant RCC
Payment Record ID 639765129
08/08/2019 Research Cash or cash equivalent Biological $36795.00 Details
Payment from E.R. Squibb & Sons, L.L.C.
Paymment Research Study Phase III Nivo Ipi Combo in 1L Bladder
Payment Record ID 639765113
02/14/2019 Research Cash or cash equivalent Biological $39180.00 Details
Payment from E.R. Squibb & Sons, L.L.C.
Paymment Research Study Phase III Neoadjuvant NSCLC nivo chemo
Payment Record ID 639765101
03/01/2019 Research Cash or cash equivalent Biological $31770.00 Details
Payment from E.R. Squibb & Sons, L.L.C.
Paymment Research Study Phase III Adjuvant HCC mono vs placebo
Payment Record ID 639765081
02/01/2019 Research Cash or cash equivalent Biological $132000.00 Details
Payment from E.R. Squibb & Sons, L.L.C.
Paymment Research Study Phase III 1L NSCLC nivo ipi chemo vs chemo in PDL-1 all comers
Payment Record ID 639765071
02/14/2019 Research Cash or cash equivalent Biological $100860.00 Details
Payment from E.R. Squibb & Sons, L.L.C.
Paymment Research Study Phase III 1L Metastatic RCC Nivo Ipi Cabo
Payment Record ID 639765061
01/16/2019 Research Cash or cash equivalent Biological $201390.00 Details
Payment from E.R. Squibb & Sons, L.L.C.
Paymment Research Study Phase III 1L Gastric nivo ipi vs nivo CT vs CT
Payment Record ID 639765043
01/16/2019 Research Cash or cash equivalent Biological $64530.00 Details
Payment from E.R. Squibb & Sons, L.L.C.
Paymment Research Study Phase III 1L Esophageal Nivo Ipi vs Nivo CT vs CT
Payment Record ID 639765029
01/16/2019 Research Cash or cash equivalent Biological $53487.50 Details
Payment from E.R. Squibb & Sons, L.L.C.
Paymment Research Study Phase IIB Signal Detection Single arm, PD-1 TNBC, SCLC, pancreatic, gastric, bladder, Ovarian Mono and Combo
Payment Record ID 639765011
11/07/2019 Research Cash or cash equivalent Biological $150.00 Details
Payment from E.R. Squibb & Sons, L.L.C.
Paymment Research Study Phase IIB MSI High CRC PMR
Payment Record ID 639765001
01/16/2019 Research Cash or cash equivalent Biological $32925.00 Details
Payment from E.R. Squibb & Sons, L.L.C.
Paymment Research Study Phase IIB Colon Cancer MSI nivo mono and combo
Payment Record ID 639764983
01/16/2019 Research Cash or cash equivalent Biological $9600.00 Details
Payment from E.R. Squibb & Sons, L.L.C.
Paymment Research Study Phase IIB 1L NSCLC nivo ipi and nivo ipi chemo
Payment Record ID 639764971
01/16/2019 Research Cash or cash equivalent Biological $19200.00 Details
Payment from E.R. Squibb & Sons, L.L.C.
Paymment Research Study Phase IIA Nivo in HL Pediatric nivo bv
Payment Record ID 639764947
01/16/2019 Research Cash or cash equivalent $31980.00 Details
Payment from E.R. Squibb & Sons, L.L.C.
Paymment Research Study Phase I IIA FIH Nivo Combination with Monotherapy Run-in
Payment Record ID 639764893
03/11/2019 Research Cash or cash equivalent Biological $12000.00 Details
Payment from E.R. Squibb & Sons, L.L.C.
Paymment Research Study Multi-Center Phase II Open-Label Study to Evaluate Safety and Efficacy in Subjects with Melanoma Metastatic to the Brain Treated with Nivolumab in Combinatiion with Ipilimumab followed by Nivolumab Monotherapy
Payment Record ID 639764791
04/10/2019 Research Cash or cash equivalent Biological $18150.00 Details
Payment from E.R. Squibb & Sons, L.L.C.
Paymment Research Study I-O CC Seattle Genetics Phase IIa combo in NHL nivo brentuximab
Payment Record ID 639764765
12/12/2019 Research Cash or cash equivalent Biological $16079.00 Details
Payment from Regeneron Pharmaceuticals, Inc.
Paymment Research Study A GLOBAL, RANDOMISED, PHASE 3, OPEN-LABEL STUDY OF REGN2810 ANTI-PD 1 ANTIBODY VERSUS PLATINUM BASED CHEMOTHERAPY IN FIRST LINE TREATMENT OF PATIENTS WITH ADVANCED OR METASTATIC PD L1NON-SMALL CELL LUNG CANCER
Clinical Trials Gov ID NCT03088540
Payment Record ID 639754319
11/14/2019 Research Cash or cash equivalent Biological $39959.50 Details
Payment from Regeneron Pharmaceuticals, Inc.
Paymment Research Study A GLOBAL, RANDOMISED, PHASE 3, OPEN-LABEL STUDY OF REGN2810 ANTI-PD 1 ANTIBODY VERSUS PLATINUM BASED CHEMOTHERAPY IN FIRST LINE TREATMENT OF PATIENTS WITH ADVANCED OR METASTATIC PD L1NON-SMALL CELL LUNG CANCER
Clinical Trials Gov ID NCT03088540
Payment Record ID 639754317
09/25/2019 Research Cash or cash equivalent Biological $17458.00 Details
Payment from Regeneron Pharmaceuticals, Inc.
Paymment Research Study A GLOBAL, RANDOMISED, PHASE 3, OPEN-LABEL STUDY OF REGN2810 ANTI-PD 1 ANTIBODY VERSUS PLATINUM BASED CHEMOTHERAPY IN FIRST LINE TREATMENT OF PATIENTS WITH ADVANCED OR METASTATIC PD L1NON-SMALL CELL LUNG CANCER
Clinical Trials Gov ID NCT03088540
Payment Record ID 639754315
09/13/2019 Research Cash or cash equivalent Biological $39959.50 Details
Payment from Regeneron Pharmaceuticals, Inc.
Paymment Research Study A GLOBAL, RANDOMISED, PHASE 3, OPEN-LABEL STUDY OF REGN2810 ANTI-PD 1 ANTIBODY VERSUS PLATINUM BASED CHEMOTHERAPY IN FIRST LINE TREATMENT OF PATIENTS WITH ADVANCED OR METASTATIC PD L1NON-SMALL CELL LUNG CANCER
Clinical Trials Gov ID NCT03088540
Payment Record ID 639754313
05/16/2019 Research Cash or cash equivalent Biological $5516.00 Details
Payment from Regeneron Pharmaceuticals, Inc.
Paymment Research Study A GLOBAL, RANDOMISED, PHASE 3, OPEN-LABEL STUDY OF REGN2810 ANTI-PD 1 ANTIBODY VERSUS PLATINUM BASED CHEMOTHERAPY IN FIRST LINE TREATMENT OF PATIENTS WITH ADVANCED OR METASTATIC PD L1NON-SMALL CELL LUNG CANCER
Clinical Trials Gov ID NCT03088540
Payment Record ID 639754311
04/04/2019 Research Cash or cash equivalent Biological $8099.00 Details
Payment from Regeneron Pharmaceuticals, Inc.
Paymment Research Study A GLOBAL, RANDOMISED, PHASE 3, OPEN-LABEL STUDY OF REGN2810 ANTI-PD 1 ANTIBODY VERSUS PLATINUM BASED CHEMOTHERAPY IN FIRST LINE TREATMENT OF PATIENTS WITH ADVANCED OR METASTATIC PD L1NON-SMALL CELL LUNG CANCER
Clinical Trials Gov ID NCT03088540
Payment Record ID 639754309
01/10/2019 Research Cash or cash equivalent Biological $29158.50 Details
Payment from Regeneron Pharmaceuticals, Inc.
Paymment Research Study A GLOBAL, RANDOMISED, PHASE 3, OPEN-LABEL STUDY OF REGN2810 ANTI-PD 1 ANTIBODY VERSUS PLATINUM BASED CHEMOTHERAPY IN FIRST LINE TREATMENT OF PATIENTS WITH ADVANCED OR METASTATIC PD L1NON-SMALL CELL LUNG CANCER
Clinical Trials Gov ID NCT03088540
Payment Record ID 639754307
05/08/2019 General (Non-Research) In-kind items and services Food and Beverage $34.80 Details
Payment from Siemens Medical Solutions USA, Inc.
Payment Record ID 631925005
08/15/2018 Research Cash or cash equivalent Biological $18120.00 Details
Payment from E.R. Squibb & Sons, L.L.C.
Paymment Research Study Phase III Nivo Ipi vs Placebo in Adjuvant RCC
Payment Record ID 618457059
07/03/2018 Research Cash or cash equivalent Biological $11030.00 Details
Payment from E.R. Squibb & Sons, L.L.C.
Paymment Research Study Phase III Neoadjuvant NSCLC nivo chemo
Payment Record ID 618457037
05/03/2018 Research Cash or cash equivalent Biological $21690.00 Details
Payment from E.R. Squibb & Sons, L.L.C.
Paymment Research Study Phase III 1L NSCLC nivo ipi chemo vs chemo in PDL 1 all comers
Payment Record ID 618457015
05/03/2018 Research Cash or cash equivalent Biological $15682.50 Details
Payment from E.R. Squibb & Sons, L.L.C.
Paymment Research Study Phase III 1L Metastatic RCC Nivo Ipi Cabo
Payment Record ID 618457009
12/03/2018 Research Cash or cash equivalent Biological $125340.00 Details
Payment from E.R. Squibb & Sons, L.L.C.
Paymment Research Study Phase III 1L Gastric nivo ipi vs nivo CT vs CT
Payment Record ID 618457003
07/03/2018 Research Cash or cash equivalent Biological $17370.00 Details
Payment from E.R. Squibb & Sons, L.L.C.
Paymment Research Study Phase III 1L Esophageal Nivo Ipi vs Nivo CT vs CT
Payment Record ID 618456995
12/03/2018 Research Cash or cash equivalent Biological $39025.00 Details
Payment from E.R. Squibb & Sons, L.L.C.
Paymment Research Study Phase IIB Signal Detection Single arm PD 1 TNBC SCLC pancreatic gastric bladder Ovarian Mono and Combo
Payment Record ID 618456983
07/03/2018 Research Cash or cash equivalent Biological $60625.00 Details
Payment from E.R. Squibb & Sons, L.L.C.
Paymment Research Study Phase IIB Colon Cancer MSI nivo mono and combo
Payment Record ID 618456975
07/03/2018 Research Cash or cash equivalent Biological $15812.50 Details
Payment from E.R. Squibb & Sons, L.L.C.
Paymment Research Study Phase IIB 1L NSCLC nivo ipi and nivo ipi chemo
Payment Record ID 618456969
12/03/2018 Research Cash or cash equivalent Biological $24375.00 Details
Payment from E.R. Squibb & Sons, L.L.C.
Paymment Research Study Phase IIA Nivo in HL Pediatric nivo bv
Payment Record ID 618456951
07/03/2018 Research Cash or cash equivalent $23850.00 Details
Payment from E.R. Squibb & Sons, L.L.C.
Paymment Research Study Phase I IIA FIH Nivo Combination with Monotherapy Run in
Payment Record ID 618456933
09/04/2018 Research Cash or cash equivalent Biological $29280.00 Details
Payment from E.R. Squibb & Sons, L.L.C.
Paymment Research Study Multi Center Phase II Open Label Study to Evaluate Safety and Efficacy in Subjects with Melanoma Metastatic to the Brain Treated with Nivolumab in Combinatiion with Ipilimumab followed by Nivolumab Monotherapy
Payment Record ID 618456925
07/11/2018 General (Non-Research) Cash or cash equivalent Consulting Fee $990.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 604798401
11/19/2018 General (Non-Research) Cash or cash equivalent Consulting Fee $990.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 604798399
11/19/2018 General (Non-Research) Cash or cash equivalent Consulting Fee $450.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 604798397
11/19/2018 General (Non-Research) Cash or cash equivalent Consulting Fee $450.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 604798291
08/29/2018 General (Non-Research) Cash or cash equivalent Consulting Fee $1080.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 604798289
07/02/2018 General (Non-Research) Cash or cash equivalent Consulting Fee $615.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 604790039
07/02/2018 General (Non-Research) Cash or cash equivalent Consulting Fee $420.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 604790037
10/17/2018 General (Non-Research) Cash or cash equivalent Consulting Fee $11049.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 604746371
10/17/2018 General (Non-Research) Cash or cash equivalent Consulting Fee $480.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 604746139
10/17/2018 General (Non-Research) Cash or cash equivalent Consulting Fee $4484.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 604746137
10/17/2018 General (Non-Research) Cash or cash equivalent Consulting Fee $3003.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 604746135
09/20/2018 General (Non-Research) Cash or cash equivalent Consulting Fee $7259.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 604667635
09/20/2018 General (Non-Research) Cash or cash equivalent Consulting Fee $542.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 604667633
09/20/2018 General (Non-Research) Cash or cash equivalent Consulting Fee $1253.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 604667631
09/20/2018 General (Non-Research) Cash or cash equivalent Consulting Fee $1165.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 604667629
04/20/2018 General (Non-Research) Cash or cash equivalent Consulting Fee $540.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 604667119
03/06/2018 General (Non-Research) Cash or cash equivalent Consulting Fee $3870.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 604667115
05/03/2018 General (Non-Research) Cash or cash equivalent Consulting Fee $780.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 604656317
05/03/2018 General (Non-Research) Cash or cash equivalent Consulting Fee $2900.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 604656313
06/07/2018 General (Non-Research) Cash or cash equivalent Consulting Fee $4108.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 604614975
07/12/2018 General (Non-Research) Cash or cash equivalent Consulting Fee $4742.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 604556875
05/10/2018 General (Non-Research) Cash or cash equivalent Consulting Fee $6567.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 604531373
05/31/2018 General (Non-Research) Cash or cash equivalent Consulting Fee $401.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 604531371
05/31/2018 General (Non-Research) Cash or cash equivalent Consulting Fee $26217.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 604531369
05/31/2018 General (Non-Research) Cash or cash equivalent Consulting Fee $1714.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 604531367
05/31/2018 General (Non-Research) Cash or cash equivalent Consulting Fee $1471.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 604531365
03/28/2018 General (Non-Research) Cash or cash equivalent Consulting Fee $4834.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 604392727
03/15/2018 General (Non-Research) Cash or cash equivalent Consulting Fee $2474.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 604392685
01/11/2018 General (Non-Research) Cash or cash equivalent Consulting Fee $9470.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 604392015
04/12/2018 General (Non-Research) Cash or cash equivalent Consulting Fee $8799.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 604392013
03/28/2018 General (Non-Research) Cash or cash equivalent Consulting Fee $8440.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 604392011
04/05/2018 General (Non-Research) Cash or cash equivalent Consulting Fee $666.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 604392009
03/22/2018 General (Non-Research) Cash or cash equivalent Consulting Fee $5102.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 604392007
04/05/2018 General (Non-Research) Cash or cash equivalent Consulting Fee $5077.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 604391901
01/11/2018 General (Non-Research) Cash or cash equivalent Consulting Fee $4814.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 604391899
01/24/2018 General (Non-Research) Cash or cash equivalent Consulting Fee $480.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 604391897
01/01/2018 General (Non-Research) Cash or cash equivalent Consulting Fee $4070.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 604391895
02/05/2018 General (Non-Research) Cash or cash equivalent Consulting Fee $40272.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 604391893
02/03/2018 General (Non-Research) Cash or cash equivalent Consulting Fee $3858.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 604391891
03/28/2018 General (Non-Research) Cash or cash equivalent Consulting Fee $16859.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 604391889
01/11/2018 General (Non-Research) Cash or cash equivalent Consulting Fee $1607.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 604391887
01/01/2018 General (Non-Research) Cash or cash equivalent Consulting Fee $1398.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 604391885
03/16/2018 General (Non-Research) Cash or cash equivalent Consulting Fee $850.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 604315613
03/16/2018 General (Non-Research) Cash or cash equivalent Consulting Fee $2520.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 604315611
05/03/2018 Research Cash or cash equivalent Drug $150.00 Details
Payment from Eli Lilly and Company
Paymment Research Study A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF RAMUCIRUMAB PLUS DOCETAXEL VERSUS PLACEBO PLUS DOCETAXEL IN PATIENTS WITH LOCALLY ADVANCED OR UNRESECTABLE OR METASTATIC UROTHELIAL CARCINOMA WHO PROGRESSED ON OR AFTER PLATINUM-BASED THERAPY
Clinical Trials Gov ID NCT02426125
Payment Record ID 585604745
11/21/2018 Research Cash or cash equivalent Biological $5862.50 Details
Payment from Regeneron Pharmaceuticals, Inc.
Paymment Research Study A GLOBAL, RANDOMISED, PHASE 3, OPEN-LABEL STUDY OF REGN2810 ANTI-PD 1 ANTIBODY VERSUS PLATINUM BASED CHEMOTHERAPY IN FIRST LINE TREATMENT OF PATIENTS WITH ADVANCED OR METASTATIC PD L1NON-SMALL CELL LUNG CANCER
Payment Record ID 577361121
09/12/2018 Research Cash or cash equivalent Biological $3900.00 Details
Payment from Regeneron Pharmaceuticals, Inc.
Paymment Research Study A GLOBAL, RANDOMISED, PHASE 3, OPEN-LABEL STUDY OF REGN2810 ANTI-PD 1 ANTIBODY VERSUS PLATINUM BASED CHEMOTHERAPY IN FIRST LINE TREATMENT OF PATIENTS WITH ADVANCED OR METASTATIC PD L1NON-SMALL CELL LUNG CANCER
Payment Record ID 577361113
07/12/2018 Research Cash or cash equivalent Biological $2940.00 Details
Payment from Regeneron Pharmaceuticals, Inc.
Paymment Research Study A GLOBAL, RANDOMISED, PHASE 3, OPEN-LABEL STUDY OF REGN2810 ANTI-PD 1 ANTIBODY VERSUS PLATINUM BASED CHEMOTHERAPY IN FIRST LINE TREATMENT OF PATIENTS WITH ADVANCED OR METASTATIC PD L1NON-SMALL CELL LUNG CANCER
Payment Record ID 577361105
05/23/2018 Research Cash or cash equivalent Biological $899.50 Details
Payment from Regeneron Pharmaceuticals, Inc.
Paymment Research Study A GLOBAL, RANDOMISED, PHASE 3, OPEN-LABEL STUDY OF REGN2810 ANTI-PD 1 ANTIBODY VERSUS PLATINUM BASED CHEMOTHERAPY IN FIRST LINE TREATMENT OF PATIENTS WITH ADVANCED OR METASTATIC PD L1NON-SMALL CELL LUNG CANCER
Payment Record ID 577361101
03/22/2018 Research Cash or cash equivalent Biological $466.67 Details
Payment from Regeneron Pharmaceuticals, Inc.
Paymment Research Study A GLOBAL, RANDOMISED, PHASE 3, OPEN-LABEL STUDY OF REGN2810 ANTI-PD 1 ANTIBODY VERSUS PLATINUM BASED CHEMOTHERAPY IN FIRST LINE TREATMENT OF PATIENTS WITH ADVANCED OR METASTATIC PD L1NON-SMALL CELL LUNG CANCER
Payment Record ID 577361095
01/11/2018 Research Cash or cash equivalent Biological $115.50 Details
Payment from Regeneron Pharmaceuticals, Inc.
Paymment Research Study A GLOBAL, RANDOMISED, PHASE 3, OPEN-LABEL STUDY OF REGN2810 ANTI-PD 1 ANTIBODY VERSUS PLATINUM BASED CHEMOTHERAPY IN FIRST LINE TREATMENT OF PATIENTS WITH ADVANCED OR METASTATIC PD L1NON-SMALL CELL LUNG CANCER
Payment Record ID 577361093
11/01/2017 General (Non-Research) Cash or cash equivalent Consulting Fee $3750.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 504874159
11/01/2017 General (Non-Research) Cash or cash equivalent Consulting Fee $1200.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 504872979
10/19/2017 General (Non-Research) Cash or cash equivalent Consulting Fee $100.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 504872941
11/29/2017 General (Non-Research) Cash or cash equivalent Consulting Fee $990.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 504851279
07/28/2017 General (Non-Research) Cash or cash equivalent Consulting Fee $7650.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 504851277
09/28/2017 General (Non-Research) Cash or cash equivalent Consulting Fee $360.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 504851275
12/20/2017 General (Non-Research) Cash or cash equivalent Consulting Fee $3060.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 504851269
08/10/2017 General (Non-Research) Cash or cash equivalent Consulting Fee $2160.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 504851265
12/20/2017 General (Non-Research) Cash or cash equivalent Consulting Fee $3340.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 504826887
11/30/2017 General (Non-Research) Cash or cash equivalent Consulting Fee $941.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 504756583
11/30/2017 General (Non-Research) Cash or cash equivalent Consulting Fee $4654.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 504756579
09/01/2017 General (Non-Research) Cash or cash equivalent Consulting Fee $500.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 504735763
09/01/2017 General (Non-Research) Cash or cash equivalent Consulting Fee $4312.50 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 504735757
07/17/2017 General (Non-Research) Cash or cash equivalent Consulting Fee $275.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 504735753
09/01/2017 General (Non-Research) Cash or cash equivalent Consulting Fee $1740.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 504735517
09/01/2017 General (Non-Research) Cash or cash equivalent Consulting Fee $112.50 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 504735489
10/25/2017 General (Non-Research) Cash or cash equivalent Consulting Fee $10816.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 504656883
10/25/2017 General (Non-Research) Cash or cash equivalent Consulting Fee $4250.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 504656039
09/14/2017 General (Non-Research) Cash or cash equivalent Consulting Fee $5054.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 504547743
09/14/2017 General (Non-Research) Cash or cash equivalent Consulting Fee $375.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 504547593
09/21/2017 General (Non-Research) Cash or cash equivalent Consulting Fee $3482.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 504547589
08/31/2017 General (Non-Research) Cash or cash equivalent Consulting Fee $4316.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 504372199
08/31/2017 General (Non-Research) Cash or cash equivalent Consulting Fee $908.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 504372185
08/31/2017 General (Non-Research) Cash or cash equivalent Consulting Fee $880.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 504371927
04/21/2017 General (Non-Research) Cash or cash equivalent Consulting Fee $360.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 504203189
03/27/2017 General (Non-Research) Cash or cash equivalent Consulting Fee $5410.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 504202005
01/27/2017 General (Non-Research) Cash or cash equivalent Consulting Fee $11790.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 504202001
05/05/2017 General (Non-Research) Cash or cash equivalent Consulting Fee $10730.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 504201997
04/07/2017 General (Non-Research) Cash or cash equivalent Consulting Fee $10548.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 504201993
04/26/2017 General (Non-Research) Cash or cash equivalent Consulting Fee $5925.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 504155165
06/15/2017 General (Non-Research) Cash or cash equivalent Consulting Fee $600.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 504089053
06/15/2017 General (Non-Research) Cash or cash equivalent Consulting Fee $5674.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 504089051
06/08/2017 General (Non-Research) Cash or cash equivalent Consulting Fee $3258.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 504089047
05/25/2017 General (Non-Research) Cash or cash equivalent Consulting Fee $5273.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 503950023
05/25/2017 General (Non-Research) Cash or cash equivalent Consulting Fee $2325.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 503950021
04/13/2017 General (Non-Research) Cash or cash equivalent Consulting Fee $1200.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 503784115
04/13/2017 General (Non-Research) Cash or cash equivalent Consulting Fee $4589.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 503783137
04/13/2017 General (Non-Research) Cash or cash equivalent Consulting Fee $10386.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 503783131
03/30/2017 General (Non-Research) Cash or cash equivalent Consulting Fee $3300.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 503713271
02/04/2017 General (Non-Research) Cash or cash equivalent Consulting Fee $2000.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 503713199
02/09/2017 General (Non-Research) Cash or cash equivalent Consulting Fee $17353.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 503713197
03/30/2017 General (Non-Research) Cash or cash equivalent Consulting Fee $1520.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 503713193
03/04/2017 General (Non-Research) Cash or cash equivalent Consulting Fee $13588.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 503713189
02/04/2017 General (Non-Research) Cash or cash equivalent Consulting Fee $11370.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 503713187
02/04/2017 General (Non-Research) Cash or cash equivalent Consulting Fee $5611.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 503712715
01/12/2017 General (Non-Research) Cash or cash equivalent Consulting Fee $600.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 503672033
11/16/2017 Research Cash or cash equivalent $1207.50 Details
Payment from Regeneron Pharmaceuticals, Inc.
Paymment Research Study A Global, Randomised, Phase 3, Open-label Study of REGN2810 ANTI-PD 1 Antibody Versus Platinum Based Chemotherapy in First Line Treatment of Patients With Advanced or Metastatic PD L1Non-small Cell Lung Cancer
Clinical Trials Gov ID NCT03088540
Payment Record ID 489533881
05/02/2017 General (Non-Research) In-kind items and services Food and Beverage $125.00 Details
Payment from Lilly USA, LLC
Payment Record ID 457735595
05/05/2017 General (Non-Research) Cash or cash equivalent Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $2100.00 Details
Payment from Lilly USA, LLC
Payment Record ID 457735593
05/02/2017 General (Non-Research) Cash or cash equivalent Travel and Lodging $7.50 Details
Payment from Lilly USA, LLC
Payment Record ID 457735591
05/02/2017 General (Non-Research) Cash or cash equivalent Travel and Lodging $24.08 Details
Payment from Lilly USA, LLC
Payment Record ID 457735589
05/02/2017 General (Non-Research) Cash or cash equivalent Consulting Fee $2800.00 Details
Payment from Lilly USA, LLC
Payment Record ID 457735587
07/17/2017 Research Cash or cash equivalent Drug $4050.00 Details
Payment from Eli Lilly and Company
Paymment Research Study A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF RAMUCIRUMAB PLUS DOCETAXEL VERSUS PLACEBO PLUS DOCETAXEL IN PATIENTS WITH LOCALLY ADVANCED OR UNRESECTABLE OR METASTATIC UROTHELIAL CARCINOMA WHO PROGRESSED ON OR AFTER PLATINUM-BASED THERAPY
Clinical Trials Gov ID NCT02426125
Payment Record ID 457098337
10/03/2016 General (Non-Research) Cash or cash equivalent Consulting Fee $58450.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 406487430
10/06/2016 General (Non-Research) Cash or cash equivalent Consulting Fee $6576.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 406079956
10/06/2016 General (Non-Research) Cash or cash equivalent Consulting Fee $1500.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 406079954
10/06/2016 General (Non-Research) Cash or cash equivalent Consulting Fee $1260.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 406079952
09/15/2016 General (Non-Research) Cash or cash equivalent Consulting Fee $5329.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 406065806
09/15/2016 General (Non-Research) Cash or cash equivalent Consulting Fee $14120.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 406065802
07/14/2016 General (Non-Research) Cash or cash equivalent Consulting Fee $1740.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 405760264
07/14/2016 General (Non-Research) Cash or cash equivalent Consulting Fee $3355.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 405759804
05/19/2016 General (Non-Research) Cash or cash equivalent Consulting Fee $1080.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 405731752
05/19/2016 General (Non-Research) Cash or cash equivalent Consulting Fee $2782.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 405729794
04/07/2016 General (Non-Research) Cash or cash equivalent Consulting Fee $6704.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 405713362
04/07/2016 General (Non-Research) Cash or cash equivalent Consulting Fee $6496.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 405713322
04/07/2016 General (Non-Research) Cash or cash equivalent Consulting Fee $480.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 405713320
01/21/2016 General (Non-Research) Cash or cash equivalent Consulting Fee $11426.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 405704226
01/13/2016 General (Non-Research) Cash or cash equivalent Consulting Fee $11301.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 405704220
03/03/2016 General (Non-Research) Cash or cash equivalent Consulting Fee $770.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 405697356
03/10/2016 General (Non-Research) Cash or cash equivalent Consulting Fee $300.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 405697354
02/11/2016 General (Non-Research) Cash or cash equivalent Consulting Fee $7086.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 405694118
10/31/2016 General (Non-Research) In-kind items and services Food and Beverage $23.89 Details
Payment from Pfizer Inc.
Payment Record ID 404851784
05/26/2016 General (Non-Research) In-kind items and services Food and Beverage $190.00 Details
Payment from Lilly USA, LLC
Payment Record ID 379233550
05/26/2016 General (Non-Research) In-kind items and services Travel and Lodging $205.85 Details
Payment from Lilly USA, LLC
Payment Record ID 379233536
05/26/2016 General (Non-Research) In-kind items and services Travel and Lodging $111.50 Details
Payment from Lilly USA, LLC
Payment Record ID 379233522
05/25/2016 General (Non-Research) In-kind items and services Travel and Lodging $551.20 Details
Payment from Lilly USA, LLC
Payment Record ID 379233512
10/07/2016 General (Non-Research) Cash or cash equivalent Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $525.00 Details
Payment from Lilly USA, LLC
Payment Record ID 379233498
10/07/2016 General (Non-Research) Cash or cash equivalent Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $1400.00 Details
Payment from Lilly USA, LLC
Payment Record ID 379233482
08/16/2016 General (Non-Research) Cash or cash equivalent Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $1400.00 Details
Payment from Lilly USA, LLC
Payment Record ID 379233470
08/16/2016 General (Non-Research) Cash or cash equivalent Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $875.00 Details
Payment from Lilly USA, LLC
Payment Record ID 379233457
07/13/2016 General (Non-Research) Cash or cash equivalent Consulting Fee $2887.50 Details
Payment from Lilly USA, LLC
Payment Record ID 379233442
;